Neoadjuvant Arterial Infusion Chemotherapy Combined With Immunotherapy in Treating Locally Advanced Lower Esophageal /Esophagogastric Junction Cancer
Qingjie Yang,
Shenghua Lv,
Qingtian Li
et al.
Abstract:Background: To retrospectively analyze the safety and efficacy of neoadjuvant arterial infusion chemotherapy combined with immunotherapy (neo-AICIT) in treating locally advanced lower esophageal cancer/esophagogastric junction cancers.
Methods: The data of patients who received neoadjuvant arterial infusion chemotherapy (docetaxel + cisplatin) combined with immunotherapy (tislelizumab) for locally advanced lower esophageal cancer or esophagogastric junction cancers from October 2021 to June 2022 were collected… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.